Merck Operating Margin 2006-2020 | MRK

Current and historical operating margin for Merck (MRK) over the last 10 years. The current operating profit margin for Merck as of March 31, 2020 is 29.18%.
Merck Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2020-03-31 $48.08B $12.81B 26.65%
2019-12-31 $46.84B $12.24B 26.13%
2019-09-30 $45.97B $12.33B 26.83%
2019-06-30 $44.37B $12.38B 27.91%
2019-03-31 $43.07B $11.19B 25.98%
2018-12-31 $42.29B $8.93B 21.12%
2018-09-30 $41.73B $8.12B 19.45%
2018-06-30 $41.26B $5.60B 13.57%
2018-03-31 $40.73B $5.86B 14.40%
2017-12-31 $40.12B $6.80B 16.94%
2017-09-30 $39.80B $3.77B 9.47%
2017-06-30 $40.02B $6.69B 16.73%
2017-03-31 $39.93B $5.82B 14.57%
2016-12-31 $39.81B $5.50B 13.81%
2016-09-30 $39.91B $8.44B 21.15%
2016-06-30 $39.44B $7.71B 19.55%
2016-03-31 $39.39B $7.79B 19.78%
2015-12-31 $39.50B $7.55B 19.11%
2015-09-30 $39.77B $7.12B 17.91%
2015-06-30 $40.25B $6.48B 16.10%
2015-03-31 $41.40B $6.15B 14.85%
2014-12-31 $42.24B $6.68B 15.82%
2014-09-30 $43.08B $7.05B 16.38%
2014-06-30 $43.55B $7.82B 17.95%
2014-03-31 $43.63B $7.90B 18.11%
2013-12-31 $44.03B $7.67B 17.41%
2013-09-30 $44.45B $7.73B 17.39%
2013-06-30 $44.91B $7.64B 17.01%
2013-03-31 $46.21B $8.94B 19.34%
2012-12-31 $47.27B $9.88B 20.90%
2012-09-30 $47.82B $9.91B 20.72%
2012-06-30 $48.36B $9.91B 20.50%
2012-03-31 $48.20B $9.54B 19.78%
2011-12-31 $48.05B $8.98B 18.68%
2011-09-30 $47.85B $6.54B 13.67%
2011-06-30 $46.95B $5.58B 11.89%
2011-03-31 $46.15B $4.62B 10.01%
2010-12-31 $45.99B $3.36B 7.30%
2010-09-30 $43.99B $3.56B 8.10%
2010-06-30 $38.91B $3.78B 9.72%
2010-03-31 $33.47B $3.76B 11.24%
2009-12-31 $27.43B $4.02B 14.66%
2009-09-30 $23.37B $5.57B 23.83%
2009-06-30 $23.26B $5.49B 23.61%
2009-03-31 $23.41B $5.63B 24.04%
2008-12-31 $23.85B $6.09B 25.51%
2008-09-30 $24.06B $6.37B 26.47%
2008-06-30 $24.19B $5.97B 24.67%
2008-03-31 $24.25B $5.86B 24.16%
2007-12-31 $24.20B $5.62B 23.22%
2007-09-30 $24.00B $4.33B 18.03%
2007-06-30 $23.33B $3.71B 15.91%
2007-03-31 $23.00B $3.69B 16.04%
2006-12-31 $22.64B $3.69B 16.28%
2006-09-30 $22.36B $4.42B 19.75%
2006-06-30 $22.36B $5.44B 24.32%
2006-03-31 $22.06B $5.63B 25.52%
2005-12-31 $22.01B $5.86B 26.62%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $207.633B $46.840B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $388.076B 16.59
Roche Holding AG (RHHBY) Switzerland $294.143B 0.00
Pfizer (PFE) United States $199.918B 12.41
Novartis AG (NVS) Switzerland $196.843B 15.36
Novo Nordisk (NVO) Denmark $151.861B 25.29
Eli Lilly (LLY) United States $142.712B 23.10
AstraZeneca (AZN) United Kingdom $141.323B 29.11
Bristol-Myers Squibb (BMY) United States $138.771B 11.59
AbbVie (ABBV) United States $138.592B 10.18
Sanofi (SNY) $125.457B 14.52
GlaxoSmithKline (GSK) United Kingdom $104.605B 12.49
Bayer (BAYRY) Germany $69.270B 9.88
H Lundbeck (HLUYY) Denmark $8.181B 14.21
Innoviva (INVA) United States $1.408B 8.13